STOK Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own STOK shares is 171, representing 107.17% of the company's common stock.

DEUTSCHE BANK AG\, in the last quarter, reduced its stake in STOK by -0.13% restricting it's holding to 412.24 thousand shares of worth nearly $5.57M. GSA CAPITAL PARTNERS LLP also lessened -4.5% of the STOK shares from its portfolio, reducing its holding to 97.51 thousand shares of worth $1.32M. BANK OF NEW YORK MELLON CORP also shunned STOK shares holding by -8.57% last quarter which brought its holding to 89.9 thousand shares worth $1.21M.

As per its latest 13F filing, CITIGROUP INC increased its stake in STOK by 37.61% in the last quarter. The institutional holder raised its holding to 5.47 thousand shares having worth more than $73.79K. SUSQUEHANNA INTERNATIONAL GROUP, LLP also added 273.64% more shares of STOK to its portfolio, raising its holding to 79.53 thousand shares of worth $1.07M. EVERSEPT PARTNERS, LP also increased its STOK shares holding by 100% which brought its holding to 290 thousand shares worth $3.92M.

The insider with the most stakes in STOK is Harrison Seth Loring , at the company. Additionally, STOK stock is highly held by 10 percent owner Apple Tree Partners IV, L.P. and 10 percent owner Skorpios Trust among others.

Company executives, directors, and other insiders own 4.67% percent of Stoke Therapeutics, Inc.'s stock. Within the last six months, there have been 13 transaction(s) in which STOK insiders have sold stock, totaling 4.02M shares. Insiders that have sold shares include SKORPIOS TRUST, ALLAN JONATHAN, and KAYE EDWARD M. MD.

There have been 0 transaction(s) during the past 6-months in which Stoke Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 16.15M Stoke Therapeutics, Inc. shares are held by insiders, which represents about 4.67% of STOK stock.

STOK , Harrison Seth Loring holds the largest portfolio of the company's shares. STOK shares owned by Harrison total nearly 17.16 million.

CITIGROUP INC is the largest institutional owner in STOK which holds 5.47 thousand shares worth $73.79K or 0.01% of the total STOK shares outstanding followed by DEUTSCHE BANK AG\ with ownership of 412.24 thousand shares representing 0.92% of the STOK ownership. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the third largest stakeholder with 79.53 thousand shares or 0.18% of the ownership worth more than $1.07M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the STOK is concerned, it is a stock which is optionable.

Number of STOK shares short is 7.48M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 52.97M shares of STOK are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, STOK has 37.27M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for STOK is 10.07.